Ignite Creation Date:
2025-12-24 @ 4:58 PM
Ignite Modification Date:
2025-12-24 @ 4:58 PM
Study NCT ID:
NCT06615050
Status:
RECRUITING
Last Update Posted:
2025-12-16
First Post:
2024-09-06
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
Sponsor:
Incyte Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-04-02
Start Date Type:
ACTUAL
Primary Completion Date:
2031-01-17
Primary Completion Date Type:
ESTIMATED
Completion Date:
2031-01-17
Completion Date Type:
ESTIMATED
First Submit Date:
2024-09-06
First Submit QC Date:
None
Study First Post Date:
2024-09-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-11
Last Update Post Date:
2025-12-16
Last Update Post Date Type:
ESTIMATED